Scientific Presentations

Publications

May 2005

William J. Kraemer, Nicholas A. Ratamess, Carl M. Maresh, Jeffrey A. Anderson, Jeff S. Volek, David P. Tiberio, Michael E. Joyce, Barry N. Messinger, Duncan N. French, Matthew J. Sharman, Martyn R. Rubin, Ana L. Gomez, Ricardo Silvestre, and Robert L. Hesslink Jr. (2005) A Cetylated Fatty Acid Topical Cream with Menthol Reduces Pain and Improves Functional Performance in Individuals with Arthritis. Journal of Strength and Conditioning Research, 19(2), 475-480.

Feb 2005

William J. Kraemer, Nicholas A. Ratamess, Carl M. Maresh, Jeffrey A. Anderson, David P. Tiberio, Michael E. Joyce, Barry N. Messinger, Duncan N. French, Matthew J. Sharman, Martyn R. Rubin, Ana L. Gomez, Jeff S. Volek, Ricardo Silvestre, Robert L. Hesslink Jr. (2005) Effects of Treatment with a Cetylated Fatty Acid Topical Cream on Static Postural Stability and Plantar Pressure Distribution in Patients with Knee Osteoarthritis. Journal of Strength and Conditioning Research, 19(1), 115 – 121

Aug 5, 2004

Kraemer W.J., Ratamess N.A., Anderson J.A., Maresh C.M., Tiberio D.P., Joyce M.E., Messinger B.NB., French D.N., Sharman M.J., Rubin M.R., Gomez A.L., Volek J.S. and Hesslink, Jr., R.L. (2004) The effects of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis. J Rheumatology, 31:767-74.

Kraemer WJ, Ratamess, NA, Anderson, JA, Tiberio, DP, Joyce, ME, Messinger, BN, Volek, JS, French, DN, Sharman, MJ, Gomez, AL, Spiering, BA, Vescovi, JD, Silvestre, R, Maresh, CM, & Hesslink Jr, RL (2004) Treatment with a cetylated fatty acid topical cream with menthol reduces pain and improves functional performance in patients with osteoarthritis. FASEB Journal 18(5):925.14, March 24, 2004.

Apr 1, 2003

Islam A, Gallaher C.M., and Gallaher D.D. (2003) Absorption and metabolism of a cetylated fatty acid. FASEB J. 17(4): A341

Oct 31, 2002

Gallaher D.D., Gallaher C.M., Hesslink R. Jr. (2002) Digestion and metabolism of cetylated fatty acids in rats. FASEB J. 16 (4): A365.

Feb 14, 2002

Hesslink Jr. R.L., Armstrong III D.A., Nagendran M.V., Sreevatsan S, and Barathur R. (2002) Cetylated fatty acids improve knee function in patients with osteoarthritis. J Rheumatology, 29:1708-1712.

2001

Barathur R.R., Bookout J.B., Sreevatsan S, Freedland E.S. and Hesslink Jr., R.L. (2001). A fatty acid ester (CMC) improves quality of lifeomes in osteoarthritis (OA) patients. FASEB J. 15(4): A265.

Presentations

2007

The effects of cetylated fatty acid cream on pain, range of motion and quality of life of patients with osteoarthritis. Kraemer WJ, Ratamess NA, Anderson JA, Tiberio DP, Joyce ME, Messinger BN, French DN, Sharman MJ, Rubin MR, Gomez AL, Volek JS, Hesslink R Jr

2003

The effects of a cetylated fatty acid cream on functional mobility and performance in patients with osteoarthritis. Ratamess NA, Kraemer WJ, Anderson JA, Tiberio DP, Joyce ME, Messinger BN, French DN, Sharman MJ, Rubin MR, Gomez AL, Volek JS, Hesslink R Jr.

2003

Absorption and metabolism of a cetylated fatty acid. Islam A, Gallaher C.M., and Gallaher D.D.

2002

Digestion and metabolism of cetylated fatty acids in rats. Gallaher D.D., Gallaher C.M., Hesslink R. Jr.

2002

The effects of a cetylated fatty acid complex on canine osteoarthritis. Hesslink R.L., and Sprouse S

2001

A fatty acid ester (CMC) improves quality of life outcomes in osteoarthritis (OA) patients. Barathur R.R., Bookout J.B., Sreevatsan S, Freedland E.S. and Hesslink Jr., R.L.

Technical Reports

2002

Bacterial reverse mutation Ames test screening. (2002) MDS Pharma, Les Oncins, France.

2002

Evaluation of topical cetylated fatty acid application to psoriasis patients. (2002) Dermatologist Medical Group of North County, Inc.

2001

The acute toxicology of oral cetylated fatty acid gavage CD-1 mouse model. (2001) Perry Scientific, Inc., Study No. 00-1075.

2000

Evaluation of a topical cream containing cetylated fatty acids using hairless mouse model. (2000) Perry Scientific, Inc., Study No. 00-1076.

Apr 1, 2003

Islam A, Gallaher C.M., and Gallaher D.D. (2003) Absorption and metabolism of a cetylated fatty acid. FASEB J. 17(4): A341

Oct 31, 2002

Gallaher D.D., Gallaher C.M., Hesslink R. Jr. (2002) Digestion and metabolism of cetylated fatty acids in rats. FASEB J. 16 (4): A365.

Feb 14, 2002

Hesslink Jr. R.L., Armstrong III D.A., Nagendran M.V., Sreevatsan S, and Barathur R. (2002) Cetylated fatty acids improve knee function in patients with osteoarthritis. J Rheumatology, 29:1708-1712.

2001

Barathur R.R., Bookout J.B., Sreevatsan S, Freedland E.S. and Hesslink Jr., R.L. (2001). A fatty acid ester (CMC) improves quality of lifeomes in osteoarthritis (OA) patients. FASEB J. 15(4): A265.